ABL Bio Inc. (KOSDAQ:298380)
South Korea · Delayed Price · Currency is KRW 157,700
+2,100 (1.35%)
Apr 10, 2026, 3:30 PM KST
199.81% (1Y)
| Market Cap | 8.71T +379.2% |
| Revenue (ttm) | 79.35B +137.6% |
| Net Income | -37.81B |
| EPS | -734.08 |
| Shares Out | 55.99M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 279,633 |
| Average Volume | 477,897 |
| Open | 157,500 |
| Previous Close | 155,600 |
| Day's Range | 154,400 - 160,500 |
| 52-Week Range | 48,600 - 257,500 |
| Beta | 0.60 |
| RSI | 40.86 |
| Earnings Date | May 13, 2026 |